Barclays lowered the firm’s price target on Novonesis (NVZMY) to DKK 500 from DKK 525 and keeps an Overweight rating on the shares.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks